Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Certified by Founder
Lodge
Korio, Inc.
start up
United States
- Doylestown, PA
- 11/10/2023
- Unknown
- $6,800,000
Korio is the industry’s leading compliance-centric Randomization & Trial Supply Management (RTSM) platform. Reflecting decades of hands-on experience across thousands of trial designs, Korio enables once aspirational goals around feature reusability, process repeatability, system performance, and overall system quality by embedding the latest RTSM design intelligence into our solution. Our intuitive approach to RTSM setup and management through a regulatory lens ensures audit-readiness and a predictable GxP compliant outcome on every clinical trial.
- Industry Software Development
- Website https://www.korioclinical.com/
- LinkedIn https://www.linkedin.com/company/korio-inc/about/
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)